Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.

Eating a healthy diet is linked to girls having their first menstrual period at an older age than those who consume a less healthy diet.

Trump signed an executive order instructing the HHS to align Medicare payments for drugs with the lowest prices paid by other nations.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right-sided lesion dissection.

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.

The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).